CION Ameerpet
Common Questions · Reviewed by CION Oncologists · NABH Accredited
How Common Is Endometrial Cancer in India?
Less common here than in Western countries, and rising. In high-income countries endometrial cancer is among the most frequent cancers affecting women; in India it has historically sat well below cervical and breast cancer, and it is increasing. The reason for that increase is not mysterious — it follows directly from rising obesity, type 2 diabetes and metabolic syndrome, which are the drivers of this disease. One caveat matters throughout: Indian cancer registry coverage is partial, endometrial cancer is likely under-recorded, and precise national figures should be treated as approximations rather than facts.
- Less common than in the West — where it is among the commonest cancers in women
- But rising, and predictably so — following obesity and diabetes prevalence
- Cervical cancer remains commoner here — which shapes what most women expect
- The data is incomplete — registry coverage is partial and this cancer is under-recorded
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The Picture, and Its Limits
It is worth being precise about what is known and what is estimated, because this is an area where confident numbers circulate without much basis.
- Incidence is lower than in the West. In high-income Western countries endometrial cancer is among the commonest cancers in women. In India it sits well below cervical and breast cancer in frequency.
- It is rising. Registry data and clinical experience both point the same way, and the drivers are well understood rather than obscure.
- Registry coverage is partial. India’s population-based cancer registries do not cover the whole population, and coverage is better in urban areas. Reported national figures are estimates built on that partial base.
- And this cancer is probably under-recorded. Women who have a hysterectomy in a smaller hospital for what is assumed to be a benign problem may never enter a registry even if cancer is found, which biases figures downward.
- So the honest summary is directional. Less common than in the West, rising, and probably somewhat commoner than the recorded figures suggest. Anyone quoting a precise national incidence to two decimal places is overstating what the data supports.
Did You Know? The rise in endometrial cancer across India is a textbook example of what epidemiologists call the metabolic transition, and it was entirely predictable. This is an oestrogen-driven cancer whose principal modifiable drivers are excess body weight and insulin resistance — both of which have increased sharply in Indian populations over recent decades, and both of which appear at lower body weights and younger ages in South Asians than in European populations. Add rising life expectancy, since this is predominantly a postmenopausal disease, and declining family size, since each pregnancy is protective, and the direction of travel follows arithmetically. Sources: ICMR National Cancer Registry Programme reports; GLOBOCAN estimates of cancer incidence and mortality, International Agency for Research on Cancer; Indian Council of Medical Research INDIAB study on diabetes prevalence.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Why It Is Rising
Every driver on this list is moving in the direction that increases endometrial cancer, and several are moving quickly.
| Driver | How it contributes |
|---|---|
| Rising obesity | The largest single factor. Fat tissue produces oestrogen independently of the ovaries, and after the menopause becomes the dominant source. See obesity and endometrial cancer. |
| Rising type 2 diabetes | India carries one of the largest diabetes burdens in the world, and insulin resistance contributes to endometrial risk through routes that operate alongside the oestrogen pathway. See diabetes and endometrial cancer. |
| The South Asian metabolic phenotype | Insulin resistance and central adiposity develop at lower body weights and roughly a decade earlier than in European populations, so cumulative exposure begins younger. See metabolic syndrome. |
| Declining family size | Each pregnancy provides months of high progesterone and no cycling, and is protective. Fewer pregnancies means less of that protection. See nulliparity and risk. |
| Rising life expectancy | This is predominantly a postmenopausal disease. More women living into the decades where it occurs means more cases, independently of any change in individual risk. |
| PCOS prevalence | Common in Indian women, closely linked to insulin resistance, and a cause of the chronic anovulation that leaves the endometrium unopposed for years. See PCOS and endometrial cancer. |
The encouraging half of that table: most of these drivers are modifiable at a population level and several are modifiable individually. Unlike cancers driven by factors nobody can change, this one has a mechanism with several practical points of interruption. See reducing your risk.
Want Your Own Risk Assessed?
Weight, waist, blood sugar, cycle history and family history together tell you far more than any national figure.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
The Numbers Describe a Population. Your Risk Is Individual.
And most of what drives it in this country is modifiable, which is more than can be said for most cancers.
What This Means in Telangana and Andhra Pradesh
The regional picture matters because the drivers are not evenly distributed across India.
- The metabolic disease burden here is high. Telangana and Andhra Pradesh have consistently reported high diabetes prevalence in national surveys, and obesity is rising alongside it.
- Risk begins at lower body weights than most people assume. International guidance applies lower thresholds for South Asians when defining central obesity, because at any given weight there is more visceral fat and more insulin resistance. A woman told her weight is fine against European standards may not be.
- Cervical cancer still dominates public understanding. Which shapes what women expect and what they have heard about — the HPV, Pap and vaccine story does not apply here at all. See endometrial versus cervical cancer.
- And there is no screening safety net. Unlike cervical cancer, nothing is watching for this in the background, so detection depends entirely on symptoms being reported and investigated. See is there a screening test.
Which makes the practical message straightforward: the single most useful thing any woman in this region can do about endometrial cancer is report abnormal bleeding promptly, and mention her weight, diabetes or family history when she does.
Worried and Want a Straight Assessment?
Your own risk factors, assessed against thresholds that apply to South Asian women. The opinion is free.
Common Questions About Endometrial Cancer
The questions people most often ask, each answered on its own page.
- What age does endometrial cancer affect?
- How fast does endometrial cancer grow & spread?
- Can a Pap smear detect endometrial cancer?
- Is there a screening test for endometrial cancer?
- Is stage 4 endometrial cancer curable?
- Is endometrial cancer painful?
- Can an ultrasound detect endometrial cancer?
- Can you have endometrial cancer without bleeding?
- Endometrial cancer life expectancy — understanding the statistics
- Is endometrial cancer caused by HPV?
Why Regional Context Changes the Assessment
Thresholds derived in European populations under-identify risk here, and the metabolic burden is high.
45-minute consultations
Scan and biopsy in one visit
Lynch counselling built in
Survivorship care that is actually offered
Second opinions welcomed, not resented
Decisions for healing, not billing
Take The Next Step
National Figures Do Not Describe You
Your weight, your cycles, your family history and your symptoms do. Those are worth assessing.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
How Common Is Endometrial Cancer in India — Frequently Asked Questions
Is endometrial cancer common in India?
Less common than in high-income Western countries, where it ranks among the most frequent cancers affecting women. In India it has historically sat well below cervical and breast cancer in frequency. However it is rising, and the reasons are well understood rather than mysterious: increasing obesity, increasing type 2 diabetes, declining family size and rising life expectancy all push in the same direction. One important caveat is that India's population-based cancer registries do not cover the whole population, coverage is better in urban areas, and endometrial cancer is likely under-recorded — so reported national figures should be treated as approximations rather than precise facts.
Why is it becoming more common here?
Because the drivers of this cancer are increasing across the Indian population. Endometrial cancer is predominantly oestrogen-driven, and its principal modifiable causes are excess body weight — because fat tissue produces oestrogen independently of the ovaries — and insulin resistance. Both have risen sharply in recent decades, and both appear at lower body weights and roughly a decade earlier in South Asians than in European populations, meaning cumulative exposure starts younger. Add declining family size, since each pregnancy provides months of protective progesterone exposure, and rising life expectancy in a predominantly postmenopausal disease, and the trend follows arithmetically.
Is it more common than cervical cancer in India?
No. Cervical cancer remains substantially more common among Indian women and accounts for a greater burden of cancer death, which is why public health messaging and public understanding have rightly focused on it. This has a practical consequence worth knowing: most women in India are familiar with the cervical cancer story — HPV, Pap smears, vaccination — and reasonably assume it applies to the womb as well. It does not. Endometrial cancer is not caused by HPV, the vaccine does not prevent it, and a normal Pap smear provides no information about the lining of the uterus.
Does it affect women in Telangana and Andhra Pradesh differently?
The drivers are more prevalent here, which matters. Both states have consistently reported high type 2 diabetes prevalence in national surveys, with obesity rising alongside. There is also a specific point about thresholds: international guidance applies lower waist circumference and body mass index cut-offs for South Asians when defining central obesity, because at any given weight South Asian women carry more visceral fat and show greater insulin resistance. A woman assessed against European standards can be told her weight is fine while carrying exactly the metabolic profile that drives endometrial risk. Ask for your waist to be measured.
What should I actually do about this?
Two things, and neither depends on national statistics. Report abnormal bleeding promptly — any bleeding after the menopause, or heavy or persistently irregular bleeding before it — and mention your weight, any diabetes and any family history of bowel or womb cancer when you do, because those details lower the threshold at which the uterine lining gets checked. There is no screening programme for this cancer, so your symptoms do the work a screening test would otherwise do. Beyond that, addressing weight and insulin resistance reduces risk, and is worth pursuing for cardiovascular reasons regardless.
Medical disclaimer: This page describes the epidemiology of endometrial cancer in India and is reviewed by a CION oncologist, drawing on ICMR National Cancer Registry Programme reports, GLOBOCAN estimates and Indian diabetes prevalence data. Indian cancer registry coverage is partial and endometrial cancer is likely under-ascertained, so figures should be regarded as approximate. Population statistics describe groups and say nothing about individual risk. If you have abnormal bleeding, see a doctor.